Forced expression of vascular endothelial growth factor-A in podocytes decreases mesangial cell numbers and attenuates endothelial cell differentiation in the mouse glomerulus
- PMID: 28776225
- DOI: 10.1007/s10157-017-1450-5
Forced expression of vascular endothelial growth factor-A in podocytes decreases mesangial cell numbers and attenuates endothelial cell differentiation in the mouse glomerulus
Abstract
Background: Glomerular podocyte-derived vascular endothelial growth factor (VEGF) is indispensable for the migration and proliferation of glomerular endothelial cells. In contrast, podocyte-specific Vegf overexpression leads to the collapse of glomerular tufts; however, the mechanisms underlying this outcome have not yet been reported.
Methods: To further clarify the effects of elevated levels of Vegf expression on glomerular cells, we established a dual transgenic mouse line in which Vegf was exclusively and inducibly expressed in podocytes under the control of the "Tet-on system" (Podocin-rtTA/TetO-Vegf164 mice).
Results: Macroscopic and microscopic examination of Podocin-rtTA/TetO-Vegf164 animals following Vegf induction identified the presence of prominent red bloody spots. In addition, the endothelial cell number was increased along with enlargement of the subendothelial spaces. We also observed impaired endothelial fenestrations and aberrant plasmalemmal vesicle-associated protein-1 (PV-1) expression. In contrast, the mesangial cell number markedly decreased, resulting in a glomerular tuft intussusceptive splitting defect. Furthermore, whereas platelet-derived growth factor-B (PDGF-B) expression in the glomerular cells of Podocin-rtTA/TetO-Vegf164 mice was not decreased, phospho-PDGF receptor immunoreactivity in the mesangial cells was significantly decreased when compared to wild-type animals.
Conclusion: Taken together, the results of this study indicated that the upregulation of podocyte VEGF decreased the number of mesangial cells, likely owing to inhibition of PDGF-B-mediated signaling.
Keywords: Glomerular development; Inducible transgenic mice; Plasmalemmal vesicle-associated protein-1; Platelet-derived growth factor.
Similar articles
-
Induction of progressive glomerulonephritis by podocyte-specific overexpression of platelet-derived growth factor-D.Kidney Int. 2011 Dec;80(12):1292-305. doi: 10.1038/ki.2011.278. Epub 2011 Aug 24. Kidney Int. 2011. PMID: 21866094
-
Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease.Kidney Int. 2010 Jun;77(11):989-99. doi: 10.1038/ki.2010.64. Epub 2010 Mar 10. Kidney Int. 2010. PMID: 20375978
-
Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival.J Am Soc Nephrol. 2006 Mar;17(3):724-35. doi: 10.1681/ASN.2005080810. Epub 2006 Jan 25. J Am Soc Nephrol. 2006. PMID: 16436493
-
Glomerular endothelial cell injury and cross talk in diabetic kidney disease.Am J Physiol Renal Physiol. 2015 Feb 15;308(4):F287-97. doi: 10.1152/ajprenal.00533.2014. Epub 2014 Nov 19. Am J Physiol Renal Physiol. 2015. PMID: 25411387 Free PMC article. Review.
-
Glomerular mesangial cell and podocyte injuries in diabetic nephropathy.Nephrology (Carlton). 2018 Oct;23 Suppl 4:32-37. doi: 10.1111/nep.13451. Nephrology (Carlton). 2018. PMID: 30298646 Review.
Cited by
-
Understanding the podocyte immune responses in proteinuric kidney diseases: from pathogenesis to therapy.Front Immunol. 2024 Jan 15;14:1335936. doi: 10.3389/fimmu.2023.1335936. eCollection 2023. Front Immunol. 2024. PMID: 38288116 Free PMC article. Review.
-
Identifying Synergistic Mechanisms of Multiple Ingredients in Shuangbai Tablets against Proteinuria by Virtual Screening and a Network Pharmacology Approach.Evid Based Complement Alternat Med. 2020 Jan 6;2020:1027271. doi: 10.1155/2020/1027271. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 32025234 Free PMC article.
-
Podocyte and endothelial-specific elimination of BAMBI identifies differential transforming growth factor-β pathways contributing to diabetic glomerulopathy.Kidney Int. 2020 Sep;98(3):601-614. doi: 10.1016/j.kint.2020.03.036. Epub 2020 Apr 26. Kidney Int. 2020. PMID: 32739209 Free PMC article.
-
Efficacy of novel agents in patients with nephropathy associated with POEMS syndrome.Int Urol Nephrol. 2022 Sep;54(9):2317-2325. doi: 10.1007/s11255-022-03120-9. Epub 2022 Feb 8. Int Urol Nephrol. 2022. PMID: 35133575 Free PMC article.
-
Site-specific expression of IQGAP1 in human nephrons.J Mol Histol. 2019 Apr;50(2):119-127. doi: 10.1007/s10735-019-09811-5. Epub 2019 Jan 19. J Mol Histol. 2019. PMID: 30659402
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials